SK
Sarvesh Kumar Paliwal
About Sarvesh Kumar Paliwal
Data last updated:
Sarvesh Kumar Paliwal is a Director at Erudition Therapeutics Private Limited (since 2024). The company operates in Paper. Erudition Therapeutics Private Limited reported revenue of ₹2 Lakh (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jun 2024 | 2024 | ₹2 Lakh (FY 2026) | Active |
Board colleagues of Sarvesh Kumar Paliwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Swapnil Sharma | 10656168 | Erudition Therapeutics Private Limited | Director |
| Vartika Paliwal | 10656169 | Erudition Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarvesh Kumar Paliwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarvesh Kumar Paliwal
Sarvesh Kumar Paliwal currently holds 1 directorship: Erudition Therapeutics Private Limited (Director, since 04 Jun 2024, revenue ₹2 Lakh (FY 2026)).
Sarvesh Kumar Paliwal was first appointed on 04 Jun 2024 as Director at Erudition Therapeutics Private Limited.
The current boards of Sarvesh Kumar Paliwal's companies include Swapnil Sharma (Erudition Therapeutics Private Limited), Vartika Paliwal (Erudition Therapeutics Private Limited).